Professor Doug Kell

Professor Doug Kell, a systems biologist and researcher, discusses his groundbreaking work on microclots and their relevance to long COVID. He explains how the SARS-CoV-2 spike protein can convert fibrinogen into bizarre amyloid-like microclots, leading to tissue hypoxia and various symptoms. Kell also delves into the potential of microclots as diagnostic biomarkers and outlines treatment strategies involving proteases. His insights link microclots to other chronic conditions, highlighting the need for better testing and therapeutic options.